Artwork
iconShare
 
Manage episode 512361868 series 1417049
Content provided by Beyond the Endpoint and Duke Clinical Research Institute. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Beyond the Endpoint and Duke Clinical Research Institute or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
In the first of a three-part series on obesity and GLP-1 medications, our guest Jennifer Norris shares the evolving landscape of obesity treatment. The conversation addresses common misconceptions and examines how GLP-1 medications, such as Ozempic, have transformed care alongside surgery and lifestyle interventions.
  continue reading

35 episodes